Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.

Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE.

Int J Surg Pathol. 2004 Jul;12(3):207-23.

PMID:
15306933
3.

Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.

Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH.

Am J Surg Pathol. 2013 Feb;37(2):167-77. doi: 10.1097/PAS.0b013e318272d428.

PMID:
23211295
4.

Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.

Farrell R, Scurry J, Otton G, Hacker NF.

Gynecol Oncol. 2005 Aug;98(2):254-62.

PMID:
15936803
6.

Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.

Giordano G, Gnetti L, Merisio C, Melpignano M.

Maturitas. 2007 Feb 20;56(2):190-7. Epub 2006 Sep 11.

PMID:
16963204
9.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.

Am J Surg Pathol. 2008 Feb;32(2):304-15. doi: 10.1097/PAS.0b013e3181483ff8.

PMID:
18223334
10.

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.

Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W.

Int J Surg Pathol. 2004 Oct;12(4):319-31.

PMID:
15494858
11.

[Clear cell carcinoma of the endometrium confined to atrophic endometrial polyp--case report].

Simon SK, Bolanca IK, Sentija K, Zovko G, Podgajski M, Valetić J, Skrtić A.

Acta Med Croatica. 2011 Sep;65 Suppl 1:143-8. Croatian.

PMID:
23126043
12.

Serous carcinoma arising in endometrial polyps: clinicopathologic study of 4 cases.

Idrees R, Din NU, Fatima S, Kayani N.

Ann Diagn Pathol. 2013 Jun;17(3):256-8. doi: 10.1016/j.anndiagpath.2012.11.003. Epub 2012 Dec 29.

PMID:
23276456
13.

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.

Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ.

Am J Surg Pathol. 1992 Jun;16(6):600-10.

PMID:
1599038
14.

Clinical parameters linked with malignancy in endometrial polyps.

Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, Papadias K, Kondi-Pafiti A, Creatsas G.

Climacteric. 2009 Oct;12(5):454-8. doi: 10.1080/13697130902912605.

PMID:
19591006
15.

[Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].

Schmidt D, Horn LC.

Zentralbl Gynakol. 2002 Jan;124(1):3-9. Review. German.

PMID:
11873307
16.
17.

Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.

Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F.

Gynecol Oncol. 2000 Aug;78(2):181-6.

PMID:
10926800
18.

[Clinical characteristics of 42 cases of malignant endometrial polyps].

Tang Z, Zhou R, Bao D, Liu C, Wei L.

Zhonghua Fu Chan Ke Za Zhi. 2014 Mar;49(3):204-7. Chinese.

PMID:
24820306
19.

[Clinical characters of pre-malignant and malignant polyp in postmenopausal women and the diagnostic value of hysteroscopy].

Zhang Y, Chen M, Guo YS, Duan H.

Zhonghua Fu Chan Ke Za Zhi. 2016 May 25;51(5):366-70. doi: 10.3760/cma.j.issn.0529-567X.2016.05.009. Chinese.

PMID:
27256445
20.

Pure compared with mixed serous endometrial carcinoma: two different entities?

Roelofsen T, van Ham MA, Wiersma van Tilburg JM, Zomer SF, Bol M, Massuger LF, Bulten J.

Obstet Gynecol. 2012 Dec;120(6):1371-81. doi: http://10.1097/AOG.0b013e318273732e.

PMID:
23168762

Supplemental Content

Support Center